What do clinical operations roles earn in DACH pharma 2026?
Clinical operations in DACH pays from junior CRA (€55,000–65,000) to head of ClinOps (€160,000–220,000). Core roles: CRA (Clinical Research Associate, monitoring), senior/lead CRA, clinical trial manager (CTM), clinical project manager (CPM), study manager, country head clinical operations. CROs (ICON, IQVIA, Parexel, Syneos Health, Labcorp, Fortrea, PPD, Medpace) are the most open employers, often with a remote contract. Big Pharma (Bayer, Roche, Novartis, Boehringer Ingelheim, AstraZeneca) pays 10–20% more but is more office-oriented.
What clinical operations actually involves
Clinical operations (ClinOps) is accountable for running Phase I–IV clinical trials to ICH-GCP. CRAs (Clinical Research Associates) monitor investigator sites, perform source data verification (SDV), protocol compliance, and ensure patient safety; travel is typically 40–60% in onsite-monitoring roles, lower in remote-CRA roles. Clinical trial managers (CTM) and clinical project managers (CPM) own one or more studies at country or multi-country level — sponsor and vendor management, timeline, budget, risk mitigation. Country head clinical operations and head of ClinOps own entire country pipelines and therapy areas with P&L and headcount responsibility. The split between sponsor and CRO fundamentally shapes salary, career path, and day-to-day reality.
Who hires clinical operations in DACH
Big Pharma sponsor affiliates: Bayer (Berlin, Wuppertal, Leverkusen), Roche (Mannheim, Penzberg), Novartis (Basel, Nuremberg), Pfizer (Berlin), Boehringer Ingelheim (Ingelheim, Vienna), AstraZeneca (Hamburg), GSK (Munich), Merck KGaA (Darmstadt), Sanofi (Frankfurt, Berlin), Janssen (Neuss), Lilly (Bad Homburg), MSD (Haar), BMS (Munich), AbbVie (Wiesbaden), Daiichi Sankyo (Munich). Specialty biotech: BioNTech, Curevac, Vertex, BioMarin, Alnylam, Moderna. CROs (top employers for remote CRA and CPM): ICON, IQVIA, Parexel, Syneos Health, Labcorp Drug Development, Fortrea, PPD (Thermo Fisher), Medpace, Worldwide Clinical Trials, Premier Research, KCR, BlueClinical. CSOs are rarely active in ClinOps.
ClinOps salary bands DACH 2026
Junior CRA (CRA I) €55,000–65,000, CRA II €65,000–78,000, senior CRA €78,000–92,000, lead CRA €92,000–108,000. Clinical trial manager €90,000–115,000, senior CTM €115,000–140,000. Clinical project manager (multi-country) €110,000–145,000, senior CPM €145,000–175,000. Country head clinical operations €150,000–200,000. Head of ClinOps DACH €175,000–220,000. Sponsor pays 10–20% more than CRO at the same level; career velocity at CROs is often faster (more studies, more indications, more responsibility in less time). Bonus typically 10–20% at sponsor, 5–15% at CRO. Remote contracts at CROs are the standard.
The hidden ClinOps job market
CRA roles are 60–70% visible via job boards (LinkedIn, Indeed, StepStone, PharmiWeb, CRO career portals). CTM and CPM are 50–60% hidden — specialist headhunters (Hays Life Sciences, Real Staffing, ProClinical, Robert Half Pharma) and direct LinkedIn outreach by in-house TA teams dominate. Head of ClinOps and country head ClinOps are 80–90% hidden — only via Egon Zehnder, Russell Reynolds, Heidrick & Struggles, or direct hiring-manager relationships. Specialty indications (oncology, rare disease, ATMP, gene therapy) have a much higher hidden share than primary care because the talent pool is smaller.
Clinical operations career paths in DACH
Standard path: CRA I (1–2 years) → CRA II (2–3 years) → senior CRA (2–3 years) → lead CRA or move to CTM → CTM (3–5 years) → CPM or senior CTM → country head ClinOps. Moves between CRO ↔ sponsor are standard — CRO brings breadth (multiple indications, multiple sponsors), sponsor brings depth (own pipeline, specialty indication) and better pay. ATMP, oncology, and rare disease experience accelerates careers significantly. My Reverse Recruitment helps time the sponsor-CRO move and approach the right hiring managers directly instead of sending 100 generic applications.
Frequently asked questions
What is the difference between CRO and sponsor for my ClinOps career?
CRO offers breadth (multiple indications, multiple sponsors, faster promotion cadence), sponsor offers depth (own pipeline, specialty indication, 10–20% higher pay). Whoever wants senior or lead level in 3–5 years benefits from CRO; whoever wants long indication immersion benefits from sponsor. Moves between both are standard and accelerate careers.
How important is ATMP/oncology experience in ClinOps 2026?
Very important. ATMP (advanced therapy medicinal products: gene, cell, tissue engineering), oncology, and rare disease are the highest-growth pipeline segments in DACH 2026. Senior CRAs and CTMs with ATMP or oncology experience earn 15–25% more and are approached 30–50% more often by headhunters than primary-care CRAs. Anyone starting in primary care should pivot into specialty after 3–5 years.
Are remote CRA roles still realistic in DACH 2026?
Yes, especially at CROs (ICON, IQVIA, Parexel, Syneos, Labcorp, Fortrea, PPD, Medpace). Remote CRA typically means 20–30% travel (instead of 50–60% in classic monitoring) — most SDV happens via remote-monitoring platforms, onsite visits only for critical visits. Big Pharma sponsor introduced office-first policies in 2024–2026, so remote CRA roles there have become rare.